Table 4 |
|||||
|
Day 28 failure rates estimated by four methods – AS+SP treatment |
|||||
| Day 28 failure rates |
|||||
|
|
|||||
| Year |
Country & Site |
Method 1a (per protocol) |
Method 1b |
Method 2a (WHO 2001) |
Method 2b |
|
|
|||||
| 2002 |
Zambia, Maheba |
21.7 |
13.2 |
15.4 |
29.8 |
| [10.9–36.4] |
[6.5–22.9] |
[8.6–26.8] |
[20.5–42.1] |
||
| 2003 |
Angola, Kuito |
1.2 |
1.2 |
1.1 |
2.3 |
| [0–6.6] |
[0–6.4] |
[0.2–7.8] |
[0.6–8.8] |
||
| 2003 |
DRC, Boende |
33.3 |
25.3 |
27.3 |
59.5 |
| [21.9–46.3] |
[16.4–36.0] |
[18.7–38.9] |
[48.8–70.5] |
||
| 2003 |
S Sudan, Nuba |
10.3 |
8.3 |
8.6 |
10.5 |
| [3.9–21.2] |
[3.1–17.3] |
[4.0–18.2] |
[5.4–19.9] |
||
| 2003 |
Uganda, Amudat |
7.9 |
6.8 |
6.8 |
8.0 |
| [2.6–17.5] |
[2.2–15.1] |
[2.9–15.5] |
[3.7–16.9] |
||
| 2004 |
Congo, Kindamba |
11.1 |
10.0 |
10.1 |
11.0 |
| [4.9–20.7] |
[4.4–18.8] |
[5.2–19.2] |
[5.9–20.2] |
||
| 2004 |
DRC, Kabalo |
2.3 |
2.0 |
2.0 |
11.8 |
| [0–12.3] |
[0–10.8] |
[0.3–13.4] |
[5.5–24.4] |
||
| 2004 |
Guinea, Dabola |
1.0 |
0.9 |
0.9 |
2.8 |
| [0–5.5] |
[0–5.2] |
[0.1–6.5] |
[0.9–8.5] |
||
|
|
|||||
|
Ashley et al. Malaria Journal 2008 7:154 doi:10.1186/1475-2875-7-154 |
|||||
